PepDiana
Back to Evidence
Primary experimental recordPositive observation

PMC8412326::ACT051952

FCLYELAR

Evidence text

Paper-level observation

Table 5: 0.65–3 kDa fraction IC50 0.303 ± 0.025 μg/mL.
tableConfidence: medium

Assay observation

Activity
Metabolic/Cardiovascular
Subtype
ACE Inhibitor
Measure
other
Comparator
=
Raw observation
0.303 ± 0.025 μg/mL
Normalized measurement
=0.303 µg/mL
Value minimum
0.278 µg/mL
Value maximum
0.328 µg/mL
Target
Oryctolagus cuniculus
Assay method
Not reported by source
Sequence
FCLYELAR
Standardization
ready simple

Source publication

A novel angiotensin I-converting enzyme inhibitory peptide derived from the trypsin hydrolysates of salmon bone proteins

PLoS ONE · 2021

DOI 10.1371/journal.pone.0256595 PMC8412326
Parent mention

Related peptide identities

PEPDIA-PLP-000669

Release PepDiana-V1-20260620. The stable record URL can be cited directly in supplementary material and downstream analyses.